| 0 |
TRACHEOSCOPY ABNORMAL |
2 |
0.6667 |
| 1 |
DYSKALAEMIA |
3 |
0.5000 |
| 2 |
RETICULOCYTE HAEMOGLOBIN DECREASED |
2 |
0.2857 |
| 3 |
MENINGITIS ASPERGILLUS |
3 |
0.2143 |
| 4 |
PARAINFLUENZA VIRUS TEST POSITIVE |
2 |
0.1538 |
| 5 |
IDH DIFFERENTIATION SYNDROME |
2 |
0.0909 |
| 6 |
RUBULAVIRUS TEST POSITIVE |
2 |
0.0769 |
| 7 |
MYOCLONIC DYSTONIA |
3 |
0.0612 |
| 8 |
LIP SQUAMOUS CELL CARCINOMA |
10 |
0.0595 |
| 9 |
ACUTE MYELOID LEUKAEMIA (IN REMISSION) |
2 |
0.0588 |
| 10 |
ENDOCARDITIS CANDIDA |
3 |
0.0395 |
| 11 |
CORYNEBACTERIUM SEPSIS |
2 |
0.0303 |
| 12 |
DEFICIENCY OF BILE SECRETION |
3 |
0.0300 |
| 13 |
COMBINED PULMONARY FIBROSIS AND EMPHYSEMA |
2 |
0.0282 |
| 14 |
ACQUIRED CORNEAL DYSTROPHY |
1 |
0.0263 |
| 15 |
MYELOBLAST COUNT INCREASED |
2 |
0.0260 |
| 16 |
CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME |
3 |
0.0242 |
| 17 |
HERPES SIMPLEX VIRAEMIA |
3 |
0.0240 |
| 18 |
ALBUMIN GLOBULIN RATIO ABNORMAL |
1 |
0.0233 |
| 19 |
ADENOVIRUS TEST POSITIVE |
2 |
0.0211 |
| 20 |
ACINETOBACTER TEST POSITIVE |
4 |
0.0206 |
| 21 |
FUSARIUM INFECTION |
13 |
0.0186 |
| 22 |
CSF VOLUME INCREASED |
2 |
0.0168 |
| 23 |
CUTANEOUS MUCORMYCOSIS |
3 |
0.0163 |
| 24 |
PULMONARY MUCORMYCOSIS |
7 |
0.0133 |
| 25 |
ENTEROBACTER BACTERAEMIA |
4 |
0.0132 |
| 26 |
COMPLICATIONS OF TRANSPLANTED LUNG |
4 |
0.0130 |
| 27 |
ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT |
4 |
0.0129 |
| 28 |
LOWER RESPIRATORY TRACT INFECTION FUNGAL |
5 |
0.0129 |
| 29 |
ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING |
3 |
0.0127 |
| 30 |
ASPERGILLOMA |
4 |
0.0125 |
| 31 |
ADMINISTRATION SITE WARMTH |
1 |
0.0122 |
| 32 |
ARTERY DISSECTION |
5 |
0.0121 |
| 33 |
EPIDERMODYSPLASIA VERRUCIFORMIS |
2 |
0.0119 |
| 34 |
HUMAN HERPESVIRUS 8 INFECTION |
7 |
0.0115 |
| 35 |
INTRACARDIAC MASS |
2 |
0.0113 |
| 36 |
PSYCHOTIC DISORDER DUE TO A GENERAL MEDICAL CONDITION |
2 |
0.0111 |
| 37 |
ASPERGILLUS INFECTION |
72 |
0.0110 |
| 38 |
MUCORMYCOSIS |
28 |
0.0108 |
| 39 |
LARYNGEAL INFLAMMATION |
2 |
0.0106 |
| 40 |
CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE |
2 |
0.0105 |
| 41 |
BURKHOLDERIA CEPACIA COMPLEX INFECTION |
3 |
0.0105 |
| 42 |
PNEUMONIA FUNGAL |
41 |
0.0104 |
| 43 |
SEPTIC PULMONARY EMBOLISM |
2 |
0.0103 |
| 44 |
ECTHYMA |
4 |
0.0100 |
| 45 |
HYPOCHROMASIA |
2 |
0.0100 |
| 46 |
CEREBRAL ASPERGILLOSIS |
6 |
0.0098 |
| 47 |
ASPERGILLUS TEST POSITIVE |
3 |
0.0097 |
| 48 |
CLOSTRIDIUM BACTERAEMIA |
2 |
0.0093 |
| 49 |
SINUSITIS FUNGAL |
7 |
0.0087 |
| 50 |
CENTRAL NERVOUS SYSTEM FUNGAL INFECTION |
2 |
0.0086 |
| 51 |
SCEDOSPORIUM INFECTION |
6 |
0.0085 |
| 52 |
SEVERE CUTANEOUS ADVERSE REACTION |
2 |
0.0084 |
| 53 |
ENTEROBACTER TEST POSITIVE |
2 |
0.0081 |
| 54 |
MICROCYTOSIS |
2 |
0.0081 |
| 55 |
ACUTE MYELOMONOCYTIC LEUKAEMIA |
2 |
0.0079 |
| 56 |
LUNG TRANSPLANT REJECTION |
5 |
0.0076 |
| 57 |
CATHETER SITE THROMBOSIS |
2 |
0.0073 |
| 58 |
ENCEPHALOMALACIA |
4 |
0.0071 |
| 59 |
CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION |
6 |
0.0067 |
| 60 |
KLEBSIELLA TEST POSITIVE |
4 |
0.0061 |
| 61 |
SEPSIS SYNDROME |
3 |
0.0060 |
| 62 |
PNEUMONIA ESCHERICHIA |
2 |
0.0059 |
| 63 |
ACUTE MYELOID LEUKAEMIA REFRACTORY |
1 |
0.0058 |
| 64 |
ANION GAP DECREASED |
2 |
0.0057 |
| 65 |
BLAST CELL COUNT INCREASED |
6 |
0.0057 |
| 66 |
ABSCESS FUNGAL |
1 |
0.0057 |
| 67 |
GRAFT VERSUS HOST DISEASE IN LIVER |
4 |
0.0056 |
| 68 |
CELL DEATH |
11 |
0.0055 |
| 69 |
COMPLICATIONS OF BONE MARROW TRANSPLANT |
2 |
0.0055 |
| 70 |
STREPTOCOCCAL BACTERAEMIA |
6 |
0.0055 |
| 71 |
ALTERNARIA INFECTION |
2 |
0.0054 |
| 72 |
LEUKAEMIA RECURRENT |
9 |
0.0053 |
| 73 |
SUSPECTED OFF LABEL USE |
24 |
0.0053 |
| 74 |
PNEUMONIA PSEUDOMONAL |
8 |
0.0052 |
| 75 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
11 |
0.0051 |
| 76 |
DISSEMINATED MUCORMYCOSIS |
2 |
0.0051 |
| 77 |
BRONCHOPULMONARY ASPERGILLOSIS |
39 |
0.0050 |
| 78 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
13 |
0.0049 |
| 79 |
ADENOVIRAL HAEMORRHAGIC CYSTITIS |
1 |
0.0048 |
| 80 |
SYSTEMIC CANDIDA |
12 |
0.0048 |
| 81 |
TRANSPLANTATION COMPLICATION |
2 |
0.0048 |
| 82 |
ADULT FAILURE TO THRIVE |
1 |
0.0047 |
| 83 |
TRANSFERRIN SATURATION DECREASED |
2 |
0.0047 |
| 84 |
PSEUDOMONAL BACTERAEMIA |
4 |
0.0047 |
| 85 |
ACUTE ON CHRONIC LIVER FAILURE |
1 |
0.0046 |
| 86 |
ACUTE MOTOR-SENSORY AXONAL NEUROPATHY |
1 |
0.0043 |
| 87 |
NEUROENDOCRINE CARCINOMA |
3 |
0.0043 |
| 88 |
SYSTEMIC MYCOSIS |
5 |
0.0043 |
| 89 |
RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE |
3 |
0.0043 |
| 90 |
AMOEBIASIS |
1 |
0.0043 |
| 91 |
BONE MARROW TRANSPLANT |
8 |
0.0042 |
| 92 |
MYCOBACTERIUM ABSCESSUS INFECTION |
3 |
0.0042 |
| 93 |
PNEUMOCYSTIS JIROVECII INFECTION |
5 |
0.0042 |
| 94 |
ARTERIOVENOUS FISTULA |
2 |
0.0041 |
| 95 |
ORBITAL OEDEMA |
2 |
0.0040 |
| 96 |
METAPNEUMOVIRUS INFECTION |
3 |
0.0038 |
| 97 |
GROWTH OF EYELASHES |
3 |
0.0038 |
| 98 |
RESPIRATORY TRACT INFECTION FUNGAL |
2 |
0.0038 |
| 99 |
DRUG LEVEL ABNORMAL |
2 |
0.0038 |
| 100 |
CHRONIC MYELOID LEUKAEMIA RECURRENT |
2 |
0.0037 |
| 101 |
MIXED LIVER INJURY |
11 |
0.0037 |
| 102 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
9 |
0.0035 |
| 103 |
SPLENIC INFARCTION |
6 |
0.0034 |
| 104 |
PROCALCITONIN INCREASED |
4 |
0.0034 |
| 105 |
LUNG TRANSPLANT |
12 |
0.0034 |
| 106 |
HYPERLEUKOCYTOSIS |
3 |
0.0034 |
| 107 |
GRAFT VERSUS HOST DISEASE |
24 |
0.0033 |
| 108 |
ACUTE MYELOID LEUKAEMIA |
52 |
0.0033 |
| 109 |
PARAINFLUENZAE VIRUS INFECTION |
5 |
0.0033 |
| 110 |
PNEUMONIA KLEBSIELLA |
6 |
0.0033 |
| 111 |
BLOOD BILIRUBIN DECREASED |
2 |
0.0032 |
| 112 |
POST-ACUTE COVID-19 SYNDROME |
4 |
0.0032 |
| 113 |
BLOOD IRON INCREASED |
6 |
0.0032 |
| 114 |
PULPITIS DENTAL |
3 |
0.0032 |
| 115 |
KLEBSIELLA BACTERAEMIA |
3 |
0.0032 |
| 116 |
INCREASED VISCOSITY OF BRONCHIAL SECRETION |
2 |
0.0031 |
| 117 |
PLATELET TRANSFUSION |
4 |
0.0031 |
| 118 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
8 |
0.0030 |
| 119 |
CARBON DIOXIDE INCREASED |
4 |
0.0029 |
| 120 |
HEART TRANSPLANT REJECTION |
3 |
0.0029 |
| 121 |
ENTEROCOCCAL BACTERAEMIA |
3 |
0.0028 |
| 122 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
17 |
0.0028 |
| 123 |
BLOOD FOLATE DECREASED |
2 |
0.0028 |
| 124 |
ARRHYTHMIA SUPRAVENTRICULAR |
3 |
0.0027 |
| 125 |
DIFFERENTIATION SYNDROME |
2 |
0.0027 |
| 126 |
OSMOTIC DEMYELINATION SYNDROME |
2 |
0.0027 |
| 127 |
CREATININE RENAL CLEARANCE INCREASED |
2 |
0.0027 |
| 128 |
CHOLANGITIS ACUTE |
2 |
0.0026 |
| 129 |
BASOPHIL COUNT INCREASED |
2 |
0.0026 |
| 130 |
FUNGAEMIA |
4 |
0.0025 |
| 131 |
DRUG LEVEL BELOW THERAPEUTIC |
14 |
0.0025 |
| 132 |
PLACENTAL INSUFFICIENCY |
2 |
0.0025 |
| 133 |
CHRONIC RESPIRATORY FAILURE |
3 |
0.0025 |
| 134 |
ENTEROCOCCAL SEPSIS |
2 |
0.0025 |
| 135 |
DYSBIOSIS |
2 |
0.0024 |
| 136 |
GLOMERULAR FILTRATION RATE INCREASED |
2 |
0.0024 |
| 137 |
DYSCHROMATOPSIA |
2 |
0.0024 |
| 138 |
RENAL ATROPHY |
3 |
0.0024 |
| 139 |
STARVATION |
2 |
0.0024 |
| 140 |
SUPERFICIAL VEIN THROMBOSIS |
2 |
0.0024 |
| 141 |
ALVEOLAR OSTEITIS |
1 |
0.0024 |
| 142 |
HYPERPHOSPHATAEMIA |
5 |
0.0023 |
| 143 |
TRANSFUSION REACTION |
2 |
0.0023 |
| 144 |
FEBRILE NEUTROPENIA |
151 |
0.0023 |
| 145 |
FOLLICULAR LYMPHOMA |
2 |
0.0023 |
| 146 |
CANDIDA SEPSIS |
2 |
0.0022 |
| 147 |
STENOTROPHOMONAS INFECTION |
3 |
0.0022 |
| 148 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
2 |
0.0022 |
| 149 |
OPPORTUNISTIC INFECTION |
4 |
0.0022 |
| 150 |
ECHOCARDIOGRAM ABNORMAL |
3 |
0.0021 |
| 151 |
VENOUS INJURY |
2 |
0.0021 |
| 152 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
3 |
0.0021 |
| 153 |
LEUKAEMIA |
20 |
0.0021 |
| 154 |
DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY |
2 |
0.0021 |
| 155 |
DELAYED RECOVERY FROM ANAESTHESIA |
2 |
0.0021 |
| 156 |
TRANSPLANT |
5 |
0.0021 |
| 157 |
POTENTIATING DRUG INTERACTION |
7 |
0.0021 |
| 158 |
RHINOVIRUS INFECTION |
8 |
0.0021 |
| 159 |
GENERALISED ANXIETY DISORDER |
3 |
0.0020 |
| 160 |
GASTROINTESTINAL WALL THICKENING |
3 |
0.0020 |
| 161 |
VASCULAR DEVICE INFECTION |
9 |
0.0020 |
| 162 |
EAR HAEMORRHAGE |
4 |
0.0020 |
| 163 |
STEROID WITHDRAWAL SYNDROME |
2 |
0.0020 |
| 164 |
GASTROSTOMY |
3 |
0.0019 |
| 165 |
LUNG OPACITY |
5 |
0.0019 |
| 166 |
OPTIC NEUROPATHY |
4 |
0.0019 |
| 167 |
ENTEROCOCCAL INFECTION |
9 |
0.0019 |
| 168 |
KIDNEY ENLARGEMENT |
2 |
0.0018 |
| 169 |
ACINETOBACTER INFECTION |
2 |
0.0018 |
| 170 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
6 |
0.0018 |
| 171 |
CYSTIC FIBROSIS |
10 |
0.0018 |
| 172 |
MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED |
3 |
0.0018 |
| 173 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
5 |
0.0018 |
| 174 |
FUNGAL INFECTION |
58 |
0.0017 |
| 175 |
CEREBRAL VENTRICLE DILATATION |
2 |
0.0017 |
| 176 |
PAROTITIS |
2 |
0.0017 |
| 177 |
APLASTIC ANAEMIA |
9 |
0.0017 |
| 178 |
TUMOUR LYSIS SYNDROME |
15 |
0.0017 |
| 179 |
AMBLYOPIA |
1 |
0.0017 |
| 180 |
ACUTE LUNG INJURY |
2 |
0.0017 |
| 181 |
NEPHROCALCINOSIS |
2 |
0.0017 |
| 182 |
COCCIDIOIDOMYCOSIS |
2 |
0.0017 |
| 183 |
ESCHERICHIA TEST POSITIVE |
2 |
0.0017 |
| 184 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
2 |
0.0017 |
| 185 |
DYSPLASIA |
2 |
0.0017 |
| 186 |
GASTROINTESTINAL TOXICITY |
8 |
0.0017 |
| 187 |
SQUAMOUS CELL CARCINOMA OF SKIN |
10 |
0.0017 |
| 188 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
9 |
0.0017 |
| 189 |
PATHOGEN RESISTANCE |
15 |
0.0016 |
| 190 |
MONOCYTE COUNT DECREASED |
2 |
0.0016 |
| 191 |
MEAN CELL HAEMOGLOBIN DECREASED |
3 |
0.0016 |
| 192 |
DISORGANISED SPEECH |
3 |
0.0016 |
| 193 |
STAPHYLOCOCCAL BACTERAEMIA |
7 |
0.0016 |
| 194 |
STEM CELL TRANSPLANT |
4 |
0.0016 |
| 195 |
NEUTROPHIL PERCENTAGE INCREASED |
2 |
0.0016 |
| 196 |
BRONCHIAL SECRETION RETENTION |
2 |
0.0016 |
| 197 |
HEPATIC CYTOLYSIS |
20 |
0.0016 |
| 198 |
ACTIVITIES OF DAILY LIVING DECREASED |
1 |
0.0016 |
| 199 |
PHYSICAL DECONDITIONING |
4 |
0.0016 |
| 200 |
SLOW RESPONSE TO STIMULI |
2 |
0.0015 |
| 201 |
PSYCHIATRIC DECOMPENSATION |
3 |
0.0015 |
| 202 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
34 |
0.0015 |
| 203 |
RESPIRATORY ACIDOSIS |
6 |
0.0015 |
| 204 |
OBLITERATIVE BRONCHIOLITIS |
2 |
0.0015 |
| 205 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
9 |
0.0015 |
| 206 |
INTESTINAL DILATATION |
2 |
0.0015 |
| 207 |
CAPILLARY LEAK SYNDROME |
3 |
0.0014 |
| 208 |
NEUTROPENIC COLITIS |
3 |
0.0014 |
| 209 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
36 |
0.0014 |
| 210 |
PERIODONTAL DISEASE |
2 |
0.0014 |
| 211 |
NEUTROPHIL COUNT ABNORMAL |
4 |
0.0014 |
| 212 |
UTERINE RUPTURE |
2 |
0.0014 |
| 213 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
3 |
0.0014 |
| 214 |
PERIODONTITIS |
3 |
0.0014 |
| 215 |
CHRONIC GRAFT VERSUS HOST DISEASE |
5 |
0.0014 |
| 216 |
GRAFT VERSUS HOST DISEASE IN SKIN |
3 |
0.0014 |
| 217 |
BACTERAEMIA |
16 |
0.0013 |
| 218 |
BONE MARROW DISORDER |
4 |
0.0013 |
| 219 |
DRUG RESISTANCE |
34 |
0.0013 |
| 220 |
PLATELET COUNT ABNORMAL |
8 |
0.0013 |
| 221 |
DRUG LEVEL ABOVE THERAPEUTIC |
6 |
0.0013 |
| 222 |
PNEUMONIA BACTERIAL |
12 |
0.0013 |
| 223 |
CYTOPENIA |
16 |
0.0013 |
| 224 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
37 |
0.0013 |
| 225 |
RED BLOOD CELL SEDIMENTATION RATE ABNORMAL |
3 |
0.0013 |
| 226 |
MEAN CELL VOLUME DECREASED |
2 |
0.0013 |
| 227 |
DRUG LEVEL DECREASED |
13 |
0.0013 |
| 228 |
ESCHERICHIA BACTERAEMIA |
3 |
0.0013 |
| 229 |
PUSTULE |
3 |
0.0013 |
| 230 |
PHARYNGEAL PARAESTHESIA |
2 |
0.0013 |
| 231 |
EOSINOPHIL COUNT DECREASED |
3 |
0.0013 |
| 232 |
WHITE BLOOD CELL COUNT ABNORMAL |
8 |
0.0013 |
| 233 |
OPTIC NERVE DISORDER |
2 |
0.0012 |
| 234 |
OFF LABEL USE |
1094 |
0.0012 |
| 235 |
ACUTE RESPIRATORY FAILURE |
24 |
0.0012 |
| 236 |
NEPHROPATHY TOXIC |
14 |
0.0012 |
| 237 |
CYTOKINE RELEASE SYNDROME |
25 |
0.0012 |
| 238 |
HAEMOGLOBIN ABNORMAL |
8 |
0.0012 |
| 239 |
FUNGAL SKIN INFECTION |
5 |
0.0012 |
| 240 |
SUFFOCATION FEELING |
3 |
0.0012 |
| 241 |
PERIPHERAL SENSORY NEUROPATHY |
7 |
0.0012 |
| 242 |
PLATELET DISORDER |
3 |
0.0012 |
| 243 |
MALIGNANT PLEURAL EFFUSION |
2 |
0.0012 |
| 244 |
BRAIN ABSCESS |
3 |
0.0012 |
| 245 |
AGRANULOCYTOSIS |
22 |
0.0012 |
| 246 |
TACHYPNOEA |
16 |
0.0012 |
| 247 |
PETIT MAL EPILEPSY |
6 |
0.0012 |
| 248 |
HEPATOSPLENOMEGALY |
3 |
0.0012 |
| 249 |
BLOOD CHLORIDE DECREASED |
3 |
0.0012 |
| 250 |
HYPERTRANSAMINASAEMIA |
8 |
0.0011 |
| 251 |
OTORRHOEA |
2 |
0.0011 |
| 252 |
PSEUDOMONAL SEPSIS |
2 |
0.0011 |
| 253 |
HISTOPLASMOSIS |
2 |
0.0011 |
| 254 |
MITRAL VALVE DISEASE |
2 |
0.0011 |
| 255 |
CYTOMEGALOVIRUS VIRAEMIA |
5 |
0.0011 |
| 256 |
STEATORRHOEA |
3 |
0.0011 |
| 257 |
HOSPICE CARE |
11 |
0.0011 |
| 258 |
NASAL OEDEMA |
2 |
0.0011 |
| 259 |
ANAEMIA OF CHRONIC DISEASE |
1 |
0.0011 |
| 260 |
DRUG LEVEL INCREASED |
18 |
0.0011 |
| 261 |
LYMPH NODE PAIN |
2 |
0.0011 |
| 262 |
MUCOSAL INFLAMMATION |
28 |
0.0011 |
| 263 |
HYPOGAMMAGLOBULINAEMIA |
7 |
0.0011 |
| 264 |
CORONAVIRUS INFECTION |
7 |
0.0011 |
| 265 |
HYPOPROTEINAEMIA |
2 |
0.0011 |
| 266 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
5 |
0.0011 |
| 267 |
BRONCHOSPASM |
15 |
0.0011 |
| 268 |
HAEMOPTYSIS |
29 |
0.0010 |
| 269 |
LUNG INFILTRATION |
9 |
0.0010 |
| 270 |
HYPERAEMIA |
2 |
0.0010 |
| 271 |
PNEUMONIA STAPHYLOCOCCAL |
2 |
0.0010 |
| 272 |
VENOOCCLUSIVE LIVER DISEASE |
5 |
0.0010 |
| 273 |
ATYPICAL PNEUMONIA |
3 |
0.0010 |
| 274 |
HEPATIC ENZYME ABNORMAL |
5 |
0.0010 |
| 275 |
BLOOD BILIRUBIN INCREASED |
27 |
0.0010 |
| 276 |
HEPATITIS CHOLESTATIC |
6 |
0.0010 |
| 277 |
DYSPHORIA |
5 |
0.0010 |
| 278 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
5 |
0.0010 |
| 279 |
RECURRENT CANCER |
4 |
0.0010 |
| 280 |
LIVER FUNCTION TEST INCREASED |
21 |
0.0010 |
| 281 |
NEUROTOXICITY |
17 |
0.0010 |
| 282 |
IMPAIRED SELF-CARE |
2 |
0.0010 |
| 283 |
BLOOD CREATININE DECREASED |
3 |
0.0010 |
| 284 |
TRANSFUSION |
10 |
0.0010 |
| 285 |
BLOOD LACTIC ACID INCREASED |
5 |
0.0009 |
| 286 |
CANDIDA INFECTION |
16 |
0.0009 |
| 287 |
CATHETER SITE ERYTHEMA |
2 |
0.0009 |
| 288 |
SEPTIC SHOCK |
40 |
0.0009 |
| 289 |
HENOCH-SCHONLEIN PURPURA |
2 |
0.0009 |
| 290 |
CEREBELLAR SYNDROME |
2 |
0.0009 |
| 291 |
NOSOCOMIAL INFECTION |
2 |
0.0009 |
| 292 |
HEPATOTOXICITY |
20 |
0.0009 |
| 293 |
CHOLECYSTITIS ACUTE |
5 |
0.0009 |
| 294 |
URINE ABNORMALITY |
4 |
0.0009 |
| 295 |
DISEASE PROGRESSION |
104 |
0.0009 |
| 296 |
ACUTE GRAFT VERSUS HOST DISEASE |
4 |
0.0009 |
| 297 |
DISEASE COMPLICATION |
4 |
0.0009 |
| 298 |
CENTRAL NERVOUS SYSTEM LESION |
12 |
0.0009 |
| 299 |
GRANULOMA |
3 |
0.0009 |
| 300 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
2 |
0.0009 |
| 301 |
RESPIRATORY TRACT INFECTION VIRAL |
2 |
0.0009 |
| 302 |
SINUS PAIN |
2 |
0.0009 |
| 303 |
TRANSAMINASES INCREASED |
19 |
0.0009 |
| 304 |
BRONCHIOLITIS |
3 |
0.0009 |
| 305 |
HYPOXIA |
30 |
0.0009 |
| 306 |
FULL BLOOD COUNT ABNORMAL |
9 |
0.0009 |
| 307 |
FIBRIN D DIMER INCREASED |
3 |
0.0008 |
| 308 |
RED BLOOD CELL COUNT DECREASED |
24 |
0.0008 |
| 309 |
MYELODYSPLASTIC SYNDROME |
12 |
0.0008 |
| 310 |
DRUG-INDUCED LIVER INJURY |
26 |
0.0008 |
| 311 |
BREATH ODOUR |
2 |
0.0008 |
| 312 |
TRANSPLANT FAILURE |
2 |
0.0008 |
| 313 |
AMYLASE INCREASED |
3 |
0.0008 |
| 314 |
STAPHYLOCOCCAL SEPSIS |
4 |
0.0008 |
| 315 |
BLOOD IMMUNOGLOBULIN G DECREASED |
2 |
0.0008 |
| 316 |
CATHETER SITE HAEMORRHAGE |
2 |
0.0008 |
| 317 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
6 |
0.0008 |
| 318 |
IMMUNOSUPPRESSION |
7 |
0.0008 |
| 319 |
URINARY TRACT INFECTION BACTERIAL |
2 |
0.0008 |
| 320 |
NEUTROPHIL COUNT INCREASED |
8 |
0.0008 |
| 321 |
ADENOCARCINOMA PANCREAS |
1 |
0.0008 |
| 322 |
FAILURE TO THRIVE |
4 |
0.0008 |
| 323 |
BLOOD POTASSIUM ABNORMAL |
2 |
0.0007 |
| 324 |
CREATININE RENAL CLEARANCE DECREASED |
3 |
0.0007 |
| 325 |
BLOOD POTASSIUM INCREASED |
12 |
0.0007 |
| 326 |
SPUTUM DISCOLOURED |
7 |
0.0007 |
| 327 |
IMMUNODEFICIENCY |
11 |
0.0007 |
| 328 |
GASTRIC PERFORATION |
2 |
0.0007 |
| 329 |
ENCEPHALOPATHY |
18 |
0.0007 |
| 330 |
BLOOD PHOSPHORUS INCREASED |
2 |
0.0007 |
| 331 |
ABSCESS ORAL |
1 |
0.0007 |
| 332 |
RHINALGIA |
2 |
0.0007 |
| 333 |
HEPATIC FUNCTION ABNORMAL |
27 |
0.0007 |
| 334 |
OBSTRUCTIVE AIRWAYS DISORDER |
8 |
0.0007 |
| 335 |
LUNG CONSOLIDATION |
2 |
0.0007 |
| 336 |
ENDOTRACHEAL INTUBATION |
2 |
0.0007 |
| 337 |
ACUTE PULMONARY OEDEMA |
4 |
0.0007 |
| 338 |
RENAL TUBULAR DISORDER |
2 |
0.0007 |
| 339 |
ALVEOLITIS |
1 |
0.0007 |
| 340 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
1 |
0.0007 |
| 341 |
PLATELET COUNT DECREASED |
75 |
0.0007 |
| 342 |
RETINAL HAEMORRHAGE |
5 |
0.0007 |
| 343 |
BACTERIAL INFECTION |
13 |
0.0007 |
| 344 |
PNEUMOTHORAX |
11 |
0.0007 |
| 345 |
FAECES SOFT |
5 |
0.0007 |
| 346 |
INCORRECT PRODUCT STORAGE |
9 |
0.0007 |
| 347 |
GINGIVAL SWELLING |
3 |
0.0007 |
| 348 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
12 |
0.0007 |
| 349 |
OSTEOMYELITIS |
12 |
0.0007 |
| 350 |
CLOSTRIDIUM DIFFICILE COLITIS |
7 |
0.0007 |
| 351 |
RESPIRATORY FAILURE |
48 |
0.0007 |
| 352 |
HYPERTHERMIA |
5 |
0.0007 |
| 353 |
FIBROSIS |
2 |
0.0006 |
| 354 |
SMALL INTESTINAL OBSTRUCTION |
8 |
0.0006 |
| 355 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
2 |
0.0006 |
| 356 |
RENAL FUNCTION TEST ABNORMAL |
3 |
0.0006 |
| 357 |
DRUG INTERACTION |
102 |
0.0006 |
| 358 |
APNOEA |
5 |
0.0006 |
| 359 |
SINUS TACHYCARDIA |
9 |
0.0006 |
| 360 |
ELECTROENCEPHALOGRAM ABNORMAL |
2 |
0.0006 |
| 361 |
NON-CARDIAC CHEST PAIN |
2 |
0.0006 |
| 362 |
HYPERKALAEMIA |
22 |
0.0006 |
| 363 |
MALNUTRITION |
7 |
0.0006 |
| 364 |
CHOLESTASIS |
12 |
0.0006 |
| 365 |
TRANSPLANT REJECTION |
5 |
0.0006 |
| 366 |
CUSHINGOID |
2 |
0.0006 |
| 367 |
ACUTE LEUKAEMIA |
1 |
0.0006 |
| 368 |
SEPSIS |
69 |
0.0006 |
| 369 |
LIVER ABSCESS |
2 |
0.0006 |
| 370 |
BACTERIAL SEPSIS |
2 |
0.0006 |
| 371 |
ESCHERICHIA INFECTION |
5 |
0.0006 |
| 372 |
HYPERVOLAEMIA |
3 |
0.0006 |
| 373 |
MUCOUS STOOLS |
3 |
0.0006 |
| 374 |
DELIRIUM |
21 |
0.0006 |
| 375 |
HYPERNATRAEMIA |
3 |
0.0006 |
| 376 |
SECOND PRIMARY MALIGNANCY |
5 |
0.0006 |
| 377 |
CARDIAC FAILURE ACUTE |
4 |
0.0006 |
| 378 |
KLEBSIELLA INFECTION |
3 |
0.0006 |
| 379 |
BK VIRUS INFECTION |
2 |
0.0006 |
| 380 |
TASTE DISORDER |
12 |
0.0006 |
| 381 |
ATAXIA |
7 |
0.0006 |
| 382 |
ELECTROCARDIOGRAM QT PROLONGED |
21 |
0.0006 |
| 383 |
ACUTE SINUSITIS |
1 |
0.0006 |
| 384 |
ACUTE KIDNEY INJURY |
88 |
0.0006 |
| 385 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
5 |
0.0006 |
| 386 |
THROMBOPHLEBITIS |
2 |
0.0006 |
| 387 |
LIVER INJURY |
14 |
0.0006 |
| 388 |
SERUM FERRITIN INCREASED |
3 |
0.0006 |
| 389 |
HALLUCINATION, VISUAL |
12 |
0.0006 |
| 390 |
SKIN WEEPING |
2 |
0.0006 |
| 391 |
INTERCEPTED PRODUCT STORAGE ERROR |
2 |
0.0006 |
| 392 |
FOOD POISONING |
3 |
0.0006 |
| 393 |
PRODUCT SIZE ISSUE |
3 |
0.0006 |
| 394 |
MONOCYTE COUNT INCREASED |
2 |
0.0006 |
| 395 |
FULL BLOOD COUNT DECREASED |
11 |
0.0005 |
| 396 |
ANAPHYLACTIC SHOCK |
14 |
0.0005 |
| 397 |
LIVER DISORDER |
24 |
0.0005 |
| 398 |
STREPTOCOCCAL INFECTION |
3 |
0.0005 |
| 399 |
NECROSIS |
3 |
0.0005 |
| 400 |
NEUTROPENIA |
73 |
0.0005 |
| 401 |
PULMONARY ALVEOLAR HAEMORRHAGE |
3 |
0.0005 |
| 402 |
PANCREATITIS ACUTE |
12 |
0.0005 |
| 403 |
PRODUCT STORAGE ISSUE |
2 |
0.0005 |
| 404 |
DIFFUSE LARGE B-CELL LYMPHOMA |
4 |
0.0005 |
| 405 |
REHABILITATION THERAPY |
2 |
0.0005 |
| 406 |
ELECTROLYTE IMBALANCE |
6 |
0.0005 |
| 407 |
LUNG INFECTION |
8 |
0.0005 |
| 408 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
1 |
0.0005 |
| 409 |
PULMONARY HAEMORRHAGE |
4 |
0.0005 |
| 410 |
GASTROINTESTINAL INFLAMMATION |
4 |
0.0005 |
| 411 |
HAEMATOCRIT DECREASED |
10 |
0.0005 |
| 412 |
BLOOD ALBUMIN DECREASED |
4 |
0.0005 |
| 413 |
HYPOMAGNESAEMIA |
7 |
0.0005 |
| 414 |
ODYNOPHAGIA |
3 |
0.0005 |
| 415 |
CEREBRAL ATROPHY |
2 |
0.0005 |
| 416 |
PROTHROMBIN TIME PROLONGED |
3 |
0.0005 |
| 417 |
RENAL IMPAIRMENT |
42 |
0.0005 |
| 418 |
HEPATIC FAILURE |
15 |
0.0005 |
| 419 |
INFECTION |
71 |
0.0005 |
| 420 |
ABNORMAL FAECES |
4 |
0.0005 |
| 421 |
HICCUPS |
4 |
0.0005 |
| 422 |
CONCOMITANT DISEASE AGGRAVATED |
3 |
0.0005 |
| 423 |
ANAPHYLACTOID REACTION |
2 |
0.0005 |
| 424 |
DYSPHAGIA |
46 |
0.0005 |
| 425 |
SOCIAL PROBLEM |
2 |
0.0005 |
| 426 |
RED CELL DISTRIBUTION WIDTH INCREASED |
2 |
0.0005 |
| 427 |
CYTOMEGALOVIRUS INFECTION |
8 |
0.0005 |
| 428 |
GASTROINTESTINAL PERFORATION |
2 |
0.0005 |
| 429 |
EPSTEIN-BARR VIRUS INFECTION |
3 |
0.0005 |
| 430 |
BLOOD SODIUM DECREASED |
9 |
0.0005 |
| 431 |
PRODUCT ODOUR ABNORMAL |
5 |
0.0005 |
| 432 |
HAEMOGLOBIN DECREASED |
49 |
0.0005 |
| 433 |
HALLUCINATIONS, MIXED |
2 |
0.0005 |
| 434 |
FACE OEDEMA |
8 |
0.0005 |
| 435 |
THROAT CANCER |
2 |
0.0005 |
| 436 |
SCREAMING |
3 |
0.0005 |
| 437 |
WHITE BLOOD CELL COUNT DECREASED |
51 |
0.0005 |
| 438 |
ENTERITIS |
3 |
0.0005 |
| 439 |
LEFT VENTRICULAR HYPERTROPHY |
2 |
0.0005 |
| 440 |
UNDERDOSE |
34 |
0.0005 |
| 441 |
METASTATIC NEOPLASM |
2 |
0.0005 |
| 442 |
POOR QUALITY DRUG ADMINISTERED |
3 |
0.0005 |
| 443 |
OXYGEN SATURATION DECREASED |
26 |
0.0005 |
| 444 |
TREATMENT FAILURE |
38 |
0.0005 |
| 445 |
JOINT STIFFNESS |
12 |
0.0005 |
| 446 |
PULMONARY FUNCTION TEST DECREASED |
2 |
0.0005 |
| 447 |
ASPIRATION |
5 |
0.0005 |
| 448 |
EOSINOPHILIA |
8 |
0.0005 |
| 449 |
PURPURA |
4 |
0.0005 |
| 450 |
MENINGITIS |
3 |
0.0004 |
| 451 |
NERVOUS SYSTEM DISORDER |
14 |
0.0004 |
| 452 |
CONDITION AGGRAVATED |
136 |
0.0004 |
| 453 |
ADENOCARCINOMA |
1 |
0.0004 |
| 454 |
MYOSITIS |
4 |
0.0004 |
| 455 |
BRONCHIECTASIS |
3 |
0.0004 |
| 456 |
NEUTROPHIL COUNT DECREASED |
18 |
0.0004 |
| 457 |
LIP DRY |
4 |
0.0004 |
| 458 |
MYOCARDIAL ISCHAEMIA |
5 |
0.0004 |
| 459 |
HYPERGLYCAEMIA |
16 |
0.0004 |
| 460 |
PNEUMONIA |
142 |
0.0004 |
| 461 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
31 |
0.0004 |
| 462 |
PYREXIA |
150 |
0.0004 |
| 463 |
CHRONIC MYELOID LEUKAEMIA |
2 |
0.0004 |
| 464 |
PERICARDIAL EFFUSION |
10 |
0.0004 |
| 465 |
INTERCEPTED MEDICATION ERROR |
2 |
0.0004 |
| 466 |
PANCYTOPENIA |
24 |
0.0004 |
| 467 |
PRODUCT USE IN UNAPPROVED INDICATION |
106 |
0.0004 |
| 468 |
SKIN TIGHTNESS |
2 |
0.0004 |
| 469 |
COVID-19 PNEUMONIA |
5 |
0.0004 |
| 470 |
PRODUCT PACKAGING ISSUE |
4 |
0.0004 |
| 471 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0004 |
| 472 |
PULSE ABSENT |
2 |
0.0004 |
| 473 |
COAGULOPATHY |
7 |
0.0004 |
| 474 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
23 |
0.0004 |
| 475 |
HYPOVOLAEMIC SHOCK |
2 |
0.0004 |
| 476 |
DRUG PRESCRIBING ERROR |
8 |
0.0004 |
| 477 |
ASPARTATE AMINOTRANSFERASE INCREASED |
22 |
0.0004 |
| 478 |
BLOOD CREATININE INCREASED |
27 |
0.0004 |
| 479 |
CLOSTRIDIUM DIFFICILE INFECTION |
9 |
0.0004 |
| 480 |
MAJOR DEPRESSION |
3 |
0.0004 |
| 481 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
7 |
0.0004 |
| 482 |
RENAL TUBULAR NECROSIS |
4 |
0.0004 |
| 483 |
ALANINE AMINOTRANSFERASE INCREASED |
25 |
0.0004 |
| 484 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
2 |
0.0004 |
| 485 |
ORGANISING PNEUMONIA |
2 |
0.0004 |
| 486 |
PULMONARY MASS |
6 |
0.0004 |
| 487 |
DEATH |
344 |
0.0004 |
| 488 |
SECRETION DISCHARGE |
5 |
0.0004 |
| 489 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
4 |
0.0004 |
| 490 |
FEEDING DISORDER |
8 |
0.0004 |
| 491 |
PLEURAL EFFUSION |
24 |
0.0004 |
| 492 |
THROMBOCYTOPENIA |
44 |
0.0004 |
| 493 |
HYPOKALAEMIA |
18 |
0.0004 |
| 494 |
DEVICE RELATED INFECTION |
6 |
0.0004 |
| 495 |
LUNG DISORDER |
19 |
0.0004 |
| 496 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
3 |
0.0004 |
| 497 |
FOETAL DEATH |
2 |
0.0004 |
| 498 |
PERIORBITAL OEDEMA |
2 |
0.0004 |
| 499 |
TREATMENT NONCOMPLIANCE |
21 |
0.0004 |
| 500 |
PLATELET COUNT INCREASED |
5 |
0.0004 |
| 501 |
PETECHIAE |
4 |
0.0004 |
| 502 |
PARTIAL SEIZURES |
2 |
0.0004 |
| 503 |
PRODUCT USE COMPLAINT |
6 |
0.0004 |
| 504 |
LIVER FUNCTION TEST ABNORMAL |
11 |
0.0004 |
| 505 |
ALCOHOL POISONING |
1 |
0.0004 |
| 506 |
ABDOMINAL MASS |
1 |
0.0004 |
| 507 |
ANAL FISSURE |
2 |
0.0004 |
| 508 |
RHINITIS |
3 |
0.0004 |
| 509 |
MUSCLE DISORDER |
3 |
0.0004 |
| 510 |
ALTERED STATE OF CONSCIOUSNESS |
8 |
0.0004 |
| 511 |
CEREBRAL INFARCTION |
9 |
0.0004 |
| 512 |
RESPIRATORY DISORDER |
11 |
0.0004 |
| 513 |
PULMONARY THROMBOSIS |
4 |
0.0004 |
| 514 |
MENTAL STATUS CHANGES |
10 |
0.0004 |
| 515 |
RASH MACULO-PAPULAR |
8 |
0.0004 |
| 516 |
BLOOD UREA INCREASED |
6 |
0.0004 |
| 517 |
CELLULITIS |
18 |
0.0004 |
| 518 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
6 |
0.0004 |
| 519 |
HEPATOCELLULAR INJURY |
5 |
0.0004 |
| 520 |
FACIAL PARALYSIS |
3 |
0.0004 |
| 521 |
PSEUDOMONAS INFECTION |
3 |
0.0003 |
| 522 |
SKIN HYPERPIGMENTATION |
3 |
0.0003 |
| 523 |
EPISTAXIS |
26 |
0.0003 |
| 524 |
HERPES VIRUS INFECTION |
2 |
0.0003 |
| 525 |
HYPERTRIGLYCERIDAEMIA |
2 |
0.0003 |
| 526 |
HOSPITALISATION |
52 |
0.0003 |
| 527 |
CHOLECYSTITIS |
4 |
0.0003 |
| 528 |
LOCALISED INFECTION |
8 |
0.0003 |
| 529 |
ADRENAL INSUFFICIENCY |
4 |
0.0003 |
| 530 |
INSURANCE ISSUE |
5 |
0.0003 |
| 531 |
PRODUCT DISPENSING ERROR |
7 |
0.0003 |
| 532 |
MELAENA |
7 |
0.0003 |
| 533 |
TACHYCARDIA |
28 |
0.0003 |
| 534 |
ULCER |
5 |
0.0003 |
| 535 |
CHROMATURIA |
7 |
0.0003 |
| 536 |
DECREASED APPETITE |
72 |
0.0003 |
| 537 |
HERPES SIMPLEX |
2 |
0.0003 |
| 538 |
HEPATITIS ACUTE |
2 |
0.0003 |
| 539 |
PHARYNGEAL SWELLING |
3 |
0.0003 |
| 540 |
BRADYPHRENIA |
2 |
0.0003 |
| 541 |
PRODUCT PREPARATION ISSUE |
2 |
0.0003 |
| 542 |
IMMUNE SYSTEM DISORDER |
4 |
0.0003 |
| 543 |
VENTRICULAR TACHYCARDIA |
5 |
0.0003 |
| 544 |
GENERALISED TONIC-CLONIC SEIZURE |
5 |
0.0003 |
| 545 |
INABILITY TO AFFORD MEDICATION |
3 |
0.0003 |
| 546 |
VIRAL INFECTION |
10 |
0.0003 |
| 547 |
LEUKOPENIA |
15 |
0.0003 |
| 548 |
TOXIC SKIN ERUPTION |
3 |
0.0003 |
| 549 |
COLITIS ISCHAEMIC |
2 |
0.0003 |
| 550 |
PRODUCT LABEL ISSUE |
2 |
0.0003 |
| 551 |
HEPATIC ENZYME INCREASED |
20 |
0.0003 |
| 552 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
3 |
0.0003 |
| 553 |
INTERSTITIAL LUNG DISEASE |
14 |
0.0003 |
| 554 |
ENCEPHALITIS |
2 |
0.0003 |
| 555 |
ORAL DISCOMFORT |
4 |
0.0003 |
| 556 |
AUTOIMMUNE HEPATITIS |
2 |
0.0003 |
| 557 |
WEIGHT FLUCTUATION |
3 |
0.0003 |
| 558 |
PAPULE |
2 |
0.0003 |
| 559 |
EATING DISORDER |
6 |
0.0003 |
| 560 |
INTENTIONAL DOSE OMISSION |
8 |
0.0003 |
| 561 |
PRODUCT SUPPLY ISSUE |
2 |
0.0003 |
| 562 |
GALLBLADDER DISORDER |
5 |
0.0003 |
| 563 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
2 |
0.0003 |
| 564 |
RENAL DISORDER |
13 |
0.0003 |
| 565 |
MYELOSUPPRESSION |
10 |
0.0003 |
| 566 |
COMPLICATION ASSOCIATED WITH DEVICE |
4 |
0.0003 |
| 567 |
FLUID OVERLOAD |
4 |
0.0003 |
| 568 |
OESOPHAGITIS |
3 |
0.0003 |
| 569 |
CARDIAC FAILURE |
22 |
0.0003 |
| 570 |
PRODUCTIVE COUGH |
13 |
0.0003 |
| 571 |
ANGIOEDEMA |
12 |
0.0003 |
| 572 |
DENTAL CARIES |
3 |
0.0003 |
| 573 |
BLINDNESS TRANSIENT |
2 |
0.0003 |
| 574 |
LABORATORY TEST ABNORMAL |
8 |
0.0003 |
| 575 |
HYPOPHOSPHATAEMIA |
2 |
0.0003 |
| 576 |
URINARY INCONTINENCE |
8 |
0.0003 |
| 577 |
COVID-19 |
47 |
0.0003 |
| 578 |
DEAFNESS |
7 |
0.0003 |
| 579 |
HYPONATRAEMIA |
15 |
0.0003 |
| 580 |
PHOTOPHOBIA |
5 |
0.0003 |
| 581 |
HYPOAESTHESIA ORAL |
4 |
0.0003 |
| 582 |
PAROSMIA |
2 |
0.0003 |
| 583 |
HYPOCALCAEMIA |
5 |
0.0003 |
| 584 |
BLOOD COUNT ABNORMAL |
4 |
0.0003 |
| 585 |
PRODUCT AVAILABILITY ISSUE |
6 |
0.0003 |
| 586 |
MYOCARDITIS |
3 |
0.0003 |
| 587 |
ACIDOSIS |
2 |
0.0003 |
| 588 |
POST PROCEDURAL COMPLICATION |
5 |
0.0003 |
| 589 |
ATRIOVENTRICULAR BLOCK |
2 |
0.0003 |
| 590 |
EJECTION FRACTION DECREASED |
4 |
0.0003 |
| 591 |
HYPOALBUMINAEMIA |
2 |
0.0003 |
| 592 |
SPLENOMEGALY |
3 |
0.0003 |
| 593 |
TORSADE DE POINTES |
2 |
0.0003 |
| 594 |
ELECTROCARDIOGRAM ABNORMAL |
2 |
0.0003 |
| 595 |
PRODUCT ADMINISTRATION INTERRUPTED |
2 |
0.0003 |
| 596 |
BLOOD IRON DECREASED |
3 |
0.0003 |
| 597 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
4 |
0.0003 |
| 598 |
THERAPY INTERRUPTED |
18 |
0.0003 |
| 599 |
CEREBRAL HAEMORRHAGE |
9 |
0.0003 |
| 600 |
GINGIVAL PAIN |
2 |
0.0003 |
| 601 |
ATRIAL FLUTTER |
2 |
0.0003 |
| 602 |
MYASTHENIA GRAVIS |
2 |
0.0002 |
| 603 |
C-REACTIVE PROTEIN INCREASED |
9 |
0.0002 |
| 604 |
BONE MARROW FAILURE |
5 |
0.0002 |
| 605 |
DECUBITUS ULCER |
2 |
0.0002 |
| 606 |
BODY TEMPERATURE INCREASED |
5 |
0.0002 |
| 607 |
CHEST PAIN |
45 |
0.0002 |
| 608 |
PNEUMONIA ASPIRATION |
6 |
0.0002 |
| 609 |
NAUSEA |
190 |
0.0002 |
| 610 |
EOSINOPHIL COUNT INCREASED |
2 |
0.0002 |
| 611 |
PRODUCT STORAGE ERROR |
21 |
0.0002 |
| 612 |
BRAIN OEDEMA |
3 |
0.0002 |
| 613 |
ACUTE MYOCARDIAL INFARCTION |
7 |
0.0002 |
| 614 |
MOUTH ULCERATION |
5 |
0.0002 |
| 615 |
MUSCLE ATROPHY |
3 |
0.0002 |
| 616 |
CIRCULATORY COLLAPSE |
4 |
0.0002 |
| 617 |
ABSCESS LIMB |
1 |
0.0002 |
| 618 |
HAEMATURIA |
8 |
0.0002 |
| 619 |
BLOOD POTASSIUM DECREASED |
7 |
0.0002 |
| 620 |
DIPLOPIA |
6 |
0.0002 |
| 621 |
STOMATITIS |
14 |
0.0002 |
| 622 |
FAECES DISCOLOURED |
5 |
0.0002 |
| 623 |
LYMPHOCYTE COUNT DECREASED |
4 |
0.0002 |
| 624 |
RESPIRATORY RATE INCREASED |
2 |
0.0002 |
| 625 |
CHEST DISCOMFORT |
23 |
0.0002 |
| 626 |
ISCHAEMIC STROKE |
4 |
0.0002 |
| 627 |
FACIAL PAIN |
2 |
0.0002 |
| 628 |
PULMONARY OEDEMA |
10 |
0.0002 |
| 629 |
THERAPY NON-RESPONDER |
10 |
0.0002 |
| 630 |
ANAL INCONTINENCE |
2 |
0.0002 |
| 631 |
PRODUCT TASTE ABNORMAL |
3 |
0.0002 |
| 632 |
GASTROENTERITIS VIRAL |
4 |
0.0002 |
| 633 |
HEART RATE IRREGULAR |
5 |
0.0002 |
| 634 |
PNEUMONITIS |
6 |
0.0002 |
| 635 |
NERVE COMPRESSION |
2 |
0.0002 |
| 636 |
PRODUCT DISTRIBUTION ISSUE |
2 |
0.0002 |
| 637 |
VOMITING |
101 |
0.0002 |
| 638 |
HEPATIC STEATOSIS |
4 |
0.0002 |
| 639 |
NEPHROPATHY |
2 |
0.0002 |
| 640 |
APPENDICITIS |
2 |
0.0002 |
| 641 |
BLOOD TEST ABNORMAL |
3 |
0.0002 |
| 642 |
SQUAMOUS CELL CARCINOMA |
2 |
0.0002 |
| 643 |
LYMPHOPENIA |
3 |
0.0002 |
| 644 |
PRODUCT DOSE OMISSION IN ERROR |
6 |
0.0002 |
| 645 |
COLITIS |
8 |
0.0002 |
| 646 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
11 |
0.0002 |
| 647 |
COUGH |
59 |
0.0002 |
| 648 |
PRODUCT PRESCRIBING ERROR |
5 |
0.0002 |
| 649 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
2 |
0.0002 |
| 650 |
CARDIOGENIC SHOCK |
3 |
0.0002 |
| 651 |
SUPRAVENTRICULAR TACHYCARDIA |
2 |
0.0002 |
| 652 |
PULMONARY FIBROSIS |
4 |
0.0002 |
| 653 |
EAR PAIN |
4 |
0.0002 |
| 654 |
APATHY |
3 |
0.0002 |
| 655 |
THROMBOTIC MICROANGIOPATHY |
2 |
0.0002 |
| 656 |
HAEMORRHOIDS |
4 |
0.0002 |
| 657 |
ORAL HERPES |
4 |
0.0002 |
| 658 |
HYPOTENSION |
41 |
0.0002 |
| 659 |
DECREASED IMMUNE RESPONSIVENESS |
2 |
0.0002 |
| 660 |
HEPATOMEGALY |
2 |
0.0002 |
| 661 |
THERAPY CHANGE |
2 |
0.0002 |
| 662 |
CARDIOMYOPATHY |
3 |
0.0002 |
| 663 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
41 |
0.0002 |
| 664 |
PRODUCT USE ISSUE |
38 |
0.0002 |
| 665 |
ABDOMINAL TENDERNESS |
1 |
0.0002 |
| 666 |
GASTROINTESTINAL DISORDER |
18 |
0.0002 |
| 667 |
HAEMORRHAGE INTRACRANIAL |
3 |
0.0002 |
| 668 |
AGEUSIA |
5 |
0.0002 |
| 669 |
DEEP VEIN THROMBOSIS |
13 |
0.0002 |
| 670 |
SLEEP DISORDER |
14 |
0.0002 |
| 671 |
PRODUCT PHYSICAL ISSUE |
4 |
0.0002 |
| 672 |
EMPHYSEMA |
2 |
0.0002 |
| 673 |
LYMPHADENOPATHY |
7 |
0.0002 |
| 674 |
TOOTH ABSCESS |
2 |
0.0002 |
| 675 |
INFUSION RELATED REACTION |
13 |
0.0002 |
| 676 |
HYPOPHAGIA |
5 |
0.0002 |
| 677 |
HEPATITIS |
5 |
0.0002 |
| 678 |
ATRIAL FIBRILLATION |
19 |
0.0002 |
| 679 |
EAR DISCOMFORT |
2 |
0.0002 |
| 680 |
NEOPLASM MALIGNANT |
13 |
0.0002 |
| 681 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
5 |
0.0002 |
| 682 |
INTENTIONAL PRODUCT USE ISSUE |
17 |
0.0002 |
| 683 |
ANAEMIA |
37 |
0.0002 |
| 684 |
MUSCULOSKELETAL CHEST PAIN |
3 |
0.0002 |
| 685 |
HYPERBILIRUBINAEMIA |
2 |
0.0002 |
| 686 |
VENTRICULAR EXTRASYSTOLES |
2 |
0.0002 |
| 687 |
DYSPNOEA |
109 |
0.0002 |
| 688 |
PULMONARY HYPERTENSION |
4 |
0.0002 |
| 689 |
RHABDOMYOLYSIS |
8 |
0.0002 |
| 690 |
GASTROINTESTINAL HAEMORRHAGE |
16 |
0.0002 |
| 691 |
BRAIN FOG |
3 |
0.0002 |
| 692 |
POOR QUALITY PRODUCT ADMINISTERED |
2 |
0.0002 |
| 693 |
DISEASE RECURRENCE |
9 |
0.0002 |
| 694 |
RESPIRATORY TRACT CONGESTION |
3 |
0.0002 |
| 695 |
BRADYCARDIA |
10 |
0.0002 |
| 696 |
DYSGEUSIA |
14 |
0.0002 |
| 697 |
RETCHING |
4 |
0.0002 |
| 698 |
CONFUSIONAL STATE |
30 |
0.0002 |
| 699 |
WHEEZING |
11 |
0.0002 |
| 700 |
OEDEMA |
10 |
0.0002 |
| 701 |
EYE DISORDER |
6 |
0.0002 |
| 702 |
WHITE BLOOD CELL COUNT INCREASED |
7 |
0.0002 |
| 703 |
SKIN LESION |
5 |
0.0002 |
| 704 |
PHOTOSENSITIVITY REACTION |
3 |
0.0002 |
| 705 |
GENERAL PHYSICAL HEALTH DETERIORATION |
21 |
0.0002 |
| 706 |
TOOTH FRACTURE |
2 |
0.0002 |
| 707 |
RESPIRATORY ARREST |
5 |
0.0002 |
| 708 |
RESPIRATORY DISTRESS |
5 |
0.0002 |
| 709 |
RENAL FAILURE |
24 |
0.0002 |
| 710 |
LOSS OF CONSCIOUSNESS |
23 |
0.0002 |
| 711 |
NEUROPATHY PERIPHERAL |
17 |
0.0002 |
| 712 |
PERICARDITIS |
3 |
0.0002 |
| 713 |
INTESTINAL PERFORATION |
2 |
0.0002 |
| 714 |
OCULAR DISCOMFORT |
2 |
0.0002 |
| 715 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
6 |
0.0002 |
| 716 |
HEMIPARESIS |
3 |
0.0002 |
| 717 |
STATUS EPILEPTICUS |
2 |
0.0002 |
| 718 |
REBOUND EFFECT |
2 |
0.0002 |
| 719 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
7 |
0.0002 |
| 720 |
DISORIENTATION |
7 |
0.0002 |
| 721 |
DIARRHOEA |
114 |
0.0002 |
| 722 |
ABDOMINAL PAIN |
41 |
0.0002 |
| 723 |
MUSCULAR WEAKNESS |
20 |
0.0002 |
| 724 |
PERIPHERAL SWELLING |
27 |
0.0002 |
| 725 |
MUSCULOSKELETAL DISCOMFORT |
3 |
0.0002 |
| 726 |
SHOCK |
4 |
0.0002 |
| 727 |
ABDOMINAL DISTENSION |
18 |
0.0002 |
| 728 |
VASCULITIS |
2 |
0.0002 |
| 729 |
CARDIAC ARREST |
14 |
0.0002 |
| 730 |
VISUAL IMPAIRMENT |
21 |
0.0002 |
| 731 |
HEAD DISCOMFORT |
3 |
0.0002 |
| 732 |
THIRST |
3 |
0.0002 |
| 733 |
CARDIO-RESPIRATORY ARREST |
7 |
0.0002 |
| 734 |
LEUKOCYTOSIS |
3 |
0.0002 |
| 735 |
DRUG INTOLERANCE |
16 |
0.0002 |
| 736 |
APHASIA |
5 |
0.0002 |
| 737 |
MENTAL IMPAIRMENT |
4 |
0.0002 |
| 738 |
NEURALGIA |
4 |
0.0002 |
| 739 |
OEDEMA PERIPHERAL |
20 |
0.0002 |
| 740 |
SOMNOLENCE |
33 |
0.0002 |
| 741 |
FEELING HOT |
10 |
0.0002 |
| 742 |
FATIGUE |
127 |
0.0002 |
| 743 |
TREMOR |
27 |
0.0002 |
| 744 |
ASTHENIA |
61 |
0.0002 |
| 745 |
CHILLS |
19 |
0.0002 |
| 746 |
HYPERCALCAEMIA |
2 |
0.0002 |
| 747 |
THROMBOSIS |
13 |
0.0002 |
| 748 |
GENERALISED OEDEMA |
2 |
0.0002 |
| 749 |
DYSPNOEA EXERTIONAL |
6 |
0.0002 |
| 750 |
BLOOD URINE PRESENT |
3 |
0.0002 |
| 751 |
CHRONIC KIDNEY DISEASE |
12 |
0.0002 |
| 752 |
PULMONARY EMBOLISM |
15 |
0.0002 |
| 753 |
HAEMATEMESIS |
4 |
0.0002 |
| 754 |
MUSCULOSKELETAL DISORDER |
3 |
0.0002 |
| 755 |
FLUID RETENTION |
8 |
0.0002 |
| 756 |
ILLNESS |
16 |
0.0002 |
| 757 |
ERUCTATION |
3 |
0.0002 |
| 758 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
11 |
0.0002 |
| 759 |
WEIGHT DECREASED |
43 |
0.0002 |
| 760 |
CHOKING |
3 |
0.0002 |
| 761 |
NODULE |
2 |
0.0002 |
| 762 |
MUSCULOSKELETAL PAIN |
8 |
0.0002 |
| 763 |
BEDRIDDEN |
2 |
0.0002 |
| 764 |
STAPHYLOCOCCAL INFECTION |
5 |
0.0002 |
| 765 |
SINUS DISORDER |
3 |
0.0002 |
| 766 |
RASH |
66 |
0.0002 |
| 767 |
VISUAL ACUITY REDUCED |
5 |
0.0002 |
| 768 |
BLOOD PRESSURE DECREASED |
10 |
0.0002 |
| 769 |
PRESCRIBED UNDERDOSE |
3 |
0.0002 |
| 770 |
EAR INFECTION |
4 |
0.0002 |
| 771 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
27 |
0.0001 |
| 772 |
SPINAL FRACTURE |
3 |
0.0001 |
| 773 |
PRODUCT DOSE OMISSION ISSUE |
44 |
0.0001 |
| 774 |
HAIR TEXTURE ABNORMAL |
2 |
0.0001 |
| 775 |
QUALITY OF LIFE DECREASED |
2 |
0.0001 |
| 776 |
JAUNDICE |
4 |
0.0001 |
| 777 |
SINUS CONGESTION |
2 |
0.0001 |
| 778 |
ARRHYTHMIA |
7 |
0.0001 |
| 779 |
VERTIGO |
9 |
0.0001 |
| 780 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
7 |
0.0001 |
| 781 |
PERIPHERAL COLDNESS |
2 |
0.0001 |
| 782 |
DIVERTICULITIS |
4 |
0.0001 |
| 783 |
INFLUENZA |
16 |
0.0001 |
| 784 |
APHONIA |
2 |
0.0001 |
| 785 |
MASS |
2 |
0.0001 |
| 786 |
BLISTER |
8 |
0.0001 |
| 787 |
DEHYDRATION |
19 |
0.0001 |
| 788 |
DISSEMINATED INTRAVASCULAR COAGULATION |
2 |
0.0001 |
| 789 |
FLATULENCE |
8 |
0.0001 |
| 790 |
ABDOMINAL PAIN UPPER |
29 |
0.0001 |
| 791 |
HYPERSOMNIA |
4 |
0.0001 |
| 792 |
HYPOACUSIS |
6 |
0.0001 |
| 793 |
ACCIDENTAL UNDERDOSE |
2 |
0.0001 |
| 794 |
SWELLING FACE |
9 |
0.0001 |
| 795 |
ANOSMIA |
2 |
0.0001 |
| 796 |
MENTAL DISORDER |
6 |
0.0001 |
| 797 |
PRODUCT DOSE OMISSION |
9 |
0.0001 |
| 798 |
PRODUCT PRESCRIBING ISSUE |
3 |
0.0001 |
| 799 |
GASTROENTERITIS |
2 |
0.0001 |
| 800 |
DYSSTASIA |
4 |
0.0001 |
| 801 |
INFLAMMATION |
7 |
0.0001 |
| 802 |
SKIN HAEMORRHAGE |
2 |
0.0001 |
| 803 |
ORAL PAIN |
3 |
0.0001 |
| 804 |
PANCREATITIS |
7 |
0.0001 |
| 805 |
DRUG INEFFECTIVE |
173 |
0.0001 |
| 806 |
ABDOMINAL DISCOMFORT |
22 |
0.0001 |
| 807 |
TINNITUS |
6 |
0.0001 |
| 808 |
SKIN DISCOLOURATION |
6 |
0.0001 |
| 809 |
MUSCLE TWITCHING |
3 |
0.0001 |
| 810 |
MALAISE |
57 |
0.0001 |
| 811 |
SEIZURE |
15 |
0.0001 |
| 812 |
LYMPHOMA |
2 |
0.0001 |
| 813 |
TENDONITIS |
2 |
0.0001 |
| 814 |
BACK PAIN |
30 |
0.0001 |
| 815 |
URINARY TRACT INFECTION |
22 |
0.0001 |
| 816 |
PLASMA CELL MYELOMA |
5 |
0.0001 |
| 817 |
CYANOSIS |
2 |
0.0001 |
| 818 |
COMA |
6 |
0.0001 |
| 819 |
OBESITY |
2 |
0.0001 |
| 820 |
RASH ERYTHEMATOUS |
6 |
0.0001 |
| 821 |
SCIATICA |
2 |
0.0001 |
| 822 |
EYE PAIN |
7 |
0.0001 |
| 823 |
MUSCLE TIGHTNESS |
2 |
0.0001 |
| 824 |
CHOLELITHIASIS |
4 |
0.0001 |
| 825 |
OSTEONECROSIS |
4 |
0.0001 |
| 826 |
LETHARGY |
7 |
0.0001 |
| 827 |
LIP SWELLING |
4 |
0.0001 |
| 828 |
GAIT INABILITY |
4 |
0.0001 |
| 829 |
HALLUCINATION |
9 |
0.0001 |
| 830 |
HOT FLUSH |
9 |
0.0001 |
| 831 |
CONSTIPATION |
26 |
0.0001 |
| 832 |
UNEVALUABLE EVENT |
9 |
0.0001 |
| 833 |
ABDOMINAL PAIN LOWER |
3 |
0.0001 |
| 834 |
MALIGNANT NEOPLASM PROGRESSION |
12 |
0.0001 |
| 835 |
SINUSITIS |
12 |
0.0001 |
| 836 |
UNRESPONSIVE TO STIMULI |
3 |
0.0001 |
| 837 |
ORTHOSTATIC HYPOTENSION |
2 |
0.0001 |
| 838 |
ARTHRITIS |
9 |
0.0001 |
| 839 |
GASTRITIS |
3 |
0.0001 |
| 840 |
HYPERTENSION |
24 |
0.0001 |
| 841 |
DRUG ERUPTION |
2 |
0.0001 |
| 842 |
DRY SKIN |
15 |
0.0001 |
| 843 |
DYSPEPSIA |
11 |
0.0001 |
| 844 |
GASTROOESOPHAGEAL REFLUX DISEASE |
9 |
0.0001 |
| 845 |
GOUT |
2 |
0.0001 |
| 846 |
THROAT IRRITATION |
5 |
0.0001 |
| 847 |
BLOOD PRESSURE INCREASED |
17 |
0.0001 |
| 848 |
TOOTHACHE |
2 |
0.0001 |
| 849 |
VISION BLURRED |
15 |
0.0001 |
| 850 |
HAEMATOCHEZIA |
6 |
0.0001 |
| 851 |
HEADACHE |
68 |
0.0001 |
| 852 |
DEMENTIA |
3 |
0.0001 |
| 853 |
ALOPECIA |
21 |
0.0001 |
| 854 |
TUBULOINTERSTITIAL NEPHRITIS |
2 |
0.0001 |
| 855 |
SKIN EXFOLIATION |
9 |
0.0001 |
| 856 |
INTESTINAL OBSTRUCTION |
4 |
0.0001 |
| 857 |
MYALGIA |
18 |
0.0001 |
| 858 |
ARTHRALGIA |
44 |
0.0001 |
| 859 |
GASTRIC ULCER |
2 |
0.0001 |
| 860 |
INCORRECT DOSE ADMINISTERED |
24 |
0.0001 |
| 861 |
SLEEP APNOEA SYNDROME |
2 |
0.0001 |
| 862 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
3 |
0.0001 |
| 863 |
AFFECT LABILITY |
1 |
0.0001 |
| 864 |
PRESCRIBED OVERDOSE |
2 |
0.0001 |
| 865 |
HYPOGLYCAEMIA |
5 |
0.0001 |
| 866 |
DYSPHONIA |
6 |
0.0001 |
| 867 |
BONE PAIN |
6 |
0.0001 |
| 868 |
SURGERY |
6 |
0.0001 |
| 869 |
SKIN FISSURES |
2 |
0.0001 |
| 870 |
NASAL CONGESTION |
6 |
0.0001 |
| 871 |
ASCITES |
3 |
0.0001 |
| 872 |
DISABILITY |
2 |
0.0001 |
| 873 |
BLOOD PRESSURE ABNORMAL |
2 |
0.0001 |
| 874 |
DRY EYE |
5 |
0.0001 |
| 875 |
CONTRAINDICATED PRODUCT ADMINISTERED |
3 |
0.0001 |
| 876 |
PRODUCT ADMINISTRATION ERROR |
2 |
0.0001 |
| 877 |
DYSKINESIA |
4 |
0.0001 |
| 878 |
BLINDNESS |
4 |
0.0001 |
| 879 |
FEMUR FRACTURE |
3 |
0.0001 |
| 880 |
SWOLLEN TONGUE |
3 |
0.0001 |
| 881 |
DEPRESSED MOOD |
5 |
0.0001 |
| 882 |
PALPITATIONS |
11 |
0.0001 |
| 883 |
HYPERHIDROSIS |
12 |
0.0001 |
| 884 |
NIGHT SWEATS |
3 |
0.0001 |
| 885 |
RHINORRHOEA |
6 |
0.0001 |
| 886 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
2 |
0.0001 |
| 887 |
RASH PRURITIC |
5 |
0.0001 |
| 888 |
IMPAIRED HEALING |
3 |
0.0001 |
| 889 |
DIZZINESS |
45 |
0.0001 |
| 890 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
4 |
0.0001 |
| 891 |
TYPE 2 DIABETES MELLITUS |
3 |
0.0001 |
| 892 |
GAIT DISTURBANCE |
17 |
0.0001 |
| 893 |
FALL |
29 |
0.0001 |
| 894 |
DRY MOUTH |
7 |
0.0001 |
| 895 |
RASH MACULAR |
3 |
0.0001 |
| 896 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
2 |
0.0001 |
| 897 |
SWELLING |
8 |
0.0001 |
| 898 |
ACCIDENT |
1 |
0.0001 |
| 899 |
CEREBROVASCULAR ACCIDENT |
14 |
0.0001 |
| 900 |
PANIC ATTACK |
3 |
0.0001 |
| 901 |
ACCIDENTAL OVERDOSE |
3 |
0.0001 |
| 902 |
BALANCE DISORDER |
7 |
0.0001 |
| 903 |
EYE SWELLING |
3 |
0.0001 |
| 904 |
HYPOAESTHESIA |
12 |
0.0001 |
| 905 |
DYSARTHRIA |
3 |
0.0001 |
| 906 |
ADVERSE DRUG REACTION |
7 |
0.0001 |
| 907 |
THERAPY CESSATION |
4 |
0.0001 |
| 908 |
ERYTHEMA |
16 |
0.0001 |
| 909 |
SKIN ULCER |
2 |
0.0001 |
| 910 |
ADVERSE REACTION |
1 |
0.0001 |
| 911 |
OVERDOSE |
16 |
0.0001 |
| 912 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 913 |
ACUTE HEPATIC FAILURE |
1 |
0.0001 |
| 914 |
URTICARIA |
12 |
0.0001 |
| 915 |
NECK PAIN |
4 |
0.0001 |
| 916 |
WOUND |
2 |
0.0001 |
| 917 |
INSOMNIA |
19 |
0.0001 |
| 918 |
INTERNATIONAL NORMALISED RATIO INCREASED |
2 |
0.0001 |
| 919 |
PAIN |
43 |
0.0001 |
| 920 |
SYNCOPE |
7 |
0.0001 |
| 921 |
PARAESTHESIA |
11 |
0.0001 |
| 922 |
HERPES ZOSTER |
4 |
0.0001 |
| 923 |
MOBILITY DECREASED |
5 |
0.0001 |
| 924 |
EYE IRRITATION |
4 |
0.0001 |
| 925 |
AGITATION |
5 |
0.0001 |
| 926 |
CATARACT |
4 |
0.0001 |
| 927 |
WEIGHT INCREASED |
15 |
0.0001 |
| 928 |
HAEMORRHAGE |
7 |
0.0001 |
| 929 |
LOWER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 930 |
ILL-DEFINED DISORDER |
4 |
0.0001 |
| 931 |
MEMORY IMPAIRMENT |
9 |
0.0001 |
| 932 |
UPPER RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 933 |
COGNITIVE DISORDER |
3 |
0.0001 |
| 934 |
MIGRAINE |
6 |
0.0001 |
| 935 |
MOOD SWINGS |
2 |
0.0001 |
| 936 |
HYPOTHYROIDISM |
2 |
0.0001 |
| 937 |
METABOLIC ACIDOSIS |
2 |
0.0001 |
| 938 |
PRURITUS |
24 |
0.0001 |
| 939 |
CARDIAC FAILURE CONGESTIVE |
5 |
0.0001 |
| 940 |
HIP FRACTURE |
2 |
0.0001 |
| 941 |
LACTIC ACIDOSIS |
2 |
0.0001 |
| 942 |
NO ADVERSE EVENT |
11 |
0.0001 |
| 943 |
DRUG DOSE OMISSION |
10 |
0.0001 |
| 944 |
MUSCLE SPASMS |
11 |
0.0001 |
| 945 |
NASOPHARYNGITIS |
11 |
0.0001 |
| 946 |
TOXICITY TO VARIOUS AGENTS |
10 |
0.0001 |
| 947 |
HYPERSENSITIVITY |
11 |
0.0001 |
| 948 |
GASTRIC DISORDER |
2 |
0.0001 |
| 949 |
SPEECH DISORDER |
3 |
0.0001 |
| 950 |
HEART RATE DECREASED |
2 |
0.0001 |
| 951 |
MATERNAL EXPOSURE DURING PREGNANCY |
5 |
0.0001 |
| 952 |
CRYING |
2 |
0.0001 |
| 953 |
DYSURIA |
2 |
0.0001 |
| 954 |
FEELING ABNORMAL |
13 |
0.0001 |
| 955 |
BRONCHITIS |
4 |
0.0001 |
| 956 |
OROPHARYNGEAL PAIN |
5 |
0.0001 |
| 957 |
CARDIAC DISORDER |
5 |
0.0001 |
| 958 |
ASTHMA |
6 |
0.0001 |
| 959 |
PAIN IN EXTREMITY |
15 |
0.0001 |
| 960 |
DISCOMFORT |
3 |
0.0000 |
| 961 |
LUNG NEOPLASM MALIGNANT |
2 |
0.0000 |
| 962 |
MUSCULOSKELETAL STIFFNESS |
4 |
0.0000 |
| 963 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 964 |
BURNING SENSATION |
3 |
0.0000 |
| 965 |
OCULAR HYPERAEMIA |
2 |
0.0000 |
| 966 |
FLUSHING |
4 |
0.0000 |
| 967 |
ANXIETY |
11 |
0.0000 |
| 968 |
BLOOD GLUCOSE INCREASED |
7 |
0.0000 |
| 969 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
| 970 |
ARTHROPATHY |
2 |
0.0000 |
| 971 |
IRRITABILITY |
2 |
0.0000 |
| 972 |
JOINT SWELLING |
4 |
0.0000 |
| 973 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 974 |
ADVERSE EVENT |
3 |
0.0000 |
| 975 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 976 |
HEART RATE INCREASED |
3 |
0.0000 |
| 977 |
MYOCARDIAL INFARCTION |
5 |
0.0000 |
| 978 |
RHEUMATOID ARTHRITIS |
3 |
0.0000 |
| 979 |
DIABETES MELLITUS |
2 |
0.0000 |
| 980 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 981 |
INJECTION SITE BRUISING |
2 |
0.0000 |
| 982 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 983 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 984 |
AMNESIA |
1 |
0.0000 |
| 985 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 986 |
ACNE |
1 |
0.0000 |
| 987 |
DEPRESSION |
3 |
0.0000 |
| 988 |
INJECTION SITE PAIN |
2 |
0.0000 |